GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.

MLA

Lahortiga, Idoya, et al. “GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.” Blood, vol. 106, no. 11, Nov. 2005, p. 2378. EBSCOhost, https://doi.org/10.1182/blood.V106.11.2378.2378.

APA

Lahortiga, I., Vazquez, I., Marcotegui, N., Bandres, E., Malumbres, R., Larrayoz, M. J., Vicente, C., Cervera, J., Hernandez, J. M., Garcia-Foncillas, J., Ardanaz, M. T., Floristan, F., Calasanz, M. J., & Odero, M. D. (2005). GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype. Blood, 106(11), 2378. https://doi.org/10.1182/blood.V106.11.2378.2378

Chicago

Lahortiga, Idoya, Iria Vazquez, Nerea Marcotegui, Eva Bandres, Raquel Malumbres, Maria J. Larrayoz, Carmen Vicente, et al. 2005. “GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.” Blood 106 (11): 2378. doi:10.1182/blood.V106.11.2378.2378.